Thurston Springer Miller Herd & Titak’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$250K	Buy	1,007 +924	+1,113%	+$199K	0.09%	214
2026 Q1	$16.8K	Hold	83	–	–	0.01%	807
2025 Q4	$17.3K	Buy	83 +60	+261%	+$12K	0.01%	789
2025 Q3	$4.15K	Sell	23 -1,234	-98%	-$210K	0.01%	431
2025 Q2	$203K	Sell	1,257 -8	-0.6%	-$1.27K	0.03%	365
2025 Q1	$216K	Buy	1,265 +62	+5%	+$10.8K	0.04%	317
2024 Q4	$200K	Sell	1,203 -7,363	-86%	-$1.26M	0.04%	278
2024 Q3	$1.47M	Buy	8,566 +26	+0.3%	+$4.3K	0.41%	61
2024 Q2	$1.32M	Buy	+8,540	New	+$1.28M	0.41%	58

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's FBT Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 1,113% in Q2 2026, buying an estimated $199K and bringing the position to 1,007 shares worth $250K. The position accounts for 0.09% of the portfolio, ranked #214.

Thurston Springer Miller Herd & Titak first reported a position in FBT in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.47M in Q3 2024. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Thurston Springer Miller Herd & Titak held 1,007 shares of First Trust NYSE Arca Biotechnology Index Fund worth $250K as of Q2 2026.
Thurston Springer Miller Herd & Titak bought 924 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $199K.
First Trust NYSE Arca Biotechnology Index Fund made up 0.09% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #214 holding.
Thurston Springer Miller Herd & Titak first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2024 and has held it in 9 quarters since.
Thurston Springer Miller Herd & Titak's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.47M in Q3 2024.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.